ICON Public Limited Company is a clinical research organization that delivers outsourced services supporting drug development and market entry across the United States, Europe, and internationally. The company assists pharmaceutical, biotech, and medical device firms through all phases of clinical trials, from early-stage studies through post-approval activities, alongside specialized services in data management, laboratory testing, site recruitment, and patient access. Its offerings span strategic consulting, trial design and execution, adaptive trial methodologies, cardiac safety assessment, decentralized trial formats, and real-world evidence generation, serving customers in cardiovascular, infectious disease, oncology, and other therapeutic areas.

entry readiness 6 · NOT READY · exit proximity 48

Value area 148.54–186.00 · 2% of 120d volume overhead · clean runway